WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies to ...
The FDA approved modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy that permit patients to take a pregnancy test outside of a medical setting during and after isotretinoin treatment ...
MedPage Today on MSN
FDA Drops Some REMS Requirements for Top Acne Medication
Test for pregnancy in medical setting before starting isotretinoin, then can be done at ho ...
The FDA plans to drop its long-standing requirement that drugmakers conduct two rigorous studies to secure approval for new drugs and is also pushing to expand over-the-counter access to medications.
Explore FDA's QMSR and cybersecurity mandates for medical devices, including SPDF, SBOMs, and legacy medical device ...
FDA Commissioner Marty Makary said he believes “everything should be over the counter” unless a drug is unsafe, addictive or requires monitoring ...
Hosted on MSN
7 foods that routinely fail FDA testing
The U.S. Food and Drug Administration (FDA) routinely tests foods sold in the United States to ensure they meet safety standards. When products fail testing, it often leads to recalls, import alerts, ...
Get a hands-on look at a torque adapter test and review conducted by classic engine experts, breaking down accuracy, usability, and real-world performance. This in-depth evaluation shows how torque ...
The FDA is freeing Intellia Therapeutics' CRISPR therapy from one of two clinical holds, allowing a phase 3 study to resume after a grade 4 liver event and subsequent patient death was reported in the ...
FDA-cleared test enables at-home detection of RSV, Flu A/B and COVID in adults and pediatric populations. SAN DIEGO, Jan. 23, 2026 /PRNewswire/ -- ACON Laboratories, Inc. today announced the retail ...
Roche Holdings AG (OTC: RHHBY) on Tuesday released topline results from the CT388-103 Phase 2 trial of CT-388 for obesity. CT-388 is an investigational once-weekly subcutaneous injectable, dual ...
JPMorgan Chase CEO Jamie Dimon called President Donald Trump's proposed 10% cap on credit card interest rates an "economic disaster." He suggested the U.S. government should test the cap in two states ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results